Stockorus.., Yes they explained at one of the CC that as the data was clean better , mortality at 28 days , improved from 24 to 31% above SOC drugs.
So even with these restriction of treatment to 2 weeks , without ANY REASONABLE explanation ,
Still 31% less patients will die with leronlimab then without..
This mean in every 100 people who died , 31 will live if given leronlimab.
And this is with 2 weeks treatment , lets see how many more lives will be saved with 4 weeks treatment..
Yes this is US medical care during this pandemic ..it is really scary ..
I am sure when within months leronlimab will be use and saving lives in many countries around the world , but not USA ,
in 1 , or 2 , or 3 years , American media may notice that and start to question.
GLTA longs.
All IMO.